Michael Berger, founder of Technical420, managing partner of StoneBridge Partners and the beloved maven behind Benzinga Cannabis Research, our cannabis stock analysis and trading subscriber-only platform, tragically passed away last…
The Department of Justice reportedly planned to issue a notice of proposed rulemaking on Thursday that would reclassify marijuana to Schedule III after a 60-day public comment period. Major players in the marijuana industry, including…
Tilray Brands is getting ready for marijuana to be reclassified as a less dangerous drug in the U.S., as the cannabis company is looking to raise money through the sale of shares so it can expand.
Shares of marijuana growers and cannabis-related companies are trading higher Thursday after President Biden announced that the Department of Justice has moved to reclassify marijuana from a Schedule I substance to a Schedule III.
Cresco Labs Inc.’s stock rose Wednesday after the U.S. cannabis-dispensary operator matched analyst estimates for first-quarter revenue, as its loss narrowed.
Wedbush Securities released a report on Curaleaf Holdings, Inc. (OTC: CURLF), the largest U.S. cannabis company by market cap, raising the stock's 12-month price target to $7.00 from $6.00 and maintaining a buy recommendation (Outperform…
Cannabis equity analysts may need to revise their 2024 earnings estimates after first-quarter results from major multi-state operators (MSOs). According to a recent report by Viridian Capital Advisors, 10 MSOs surpassed EBITDA estimates by…
Shares of Cronos Group Inc. traded sharply higher Thursday after the cannabis company, citing strength in flower sales, reported first-quarter revenue that rose to a record and beat expectations.
Marijuana ETFs and cannabis stocks shot higher last week after the U.S. Justice Department said it plans to reclassify marijuana as a less dangerous drug.
Last Tuesday's breaking news of cannabis rescheduling drove the cannabis industry into overdrive with elated thoughts from tax relief to soaring marijuana stocks to cannabis scientists presuming they no longer have to keep their research…